Investigators sought to evaluate changes in the estimated CV risk of men with prostate cancer after 6 months of hormone therapy using clinical tools established for the general population.
Stage 3 prostate cancer is locally advanced, with tumors extending beyond the prostate but not metastasizing distantly.
A University of Kentucky Markey Cancer Center study reveals how prostate cancer cells adapt their metabolism to thrive in ...
In a recent interview with CURE, Dr. Kai Tsao broke down current treatment advancements for patients with prostate cancer.
A study co-led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center found that most of the benefits of androgen deprivation therapy (ADT) for prostate cancer occur within the first ...
A study co-led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center found that most of the benefits of androgen deprivation therapy (ADT) for prostate cancer occur within the first ...
Discusses Innovative Approaches for Thyroid Artery Embolization and Tumor-Targeted Therapies December 15, 2025 2:00 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback